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Abstract
Background: To provide useful insights into the design of strategies to better 
put into practice health research outcomes in the case of cancer, heart disease 
and sexuallty transmitted infections, we designed a study to identify barriers and 
facilitators to implement clinical or public health guidelines recommendations.
Methods: A literature review protocol was designed and studies were 
retrieved from the MedLine database for the period 2009-2011. Studies were 
classified as high, moderate or poor quality according to a specific protocol for 
each type of study (quantitative, qualitative, review).
Results: A total of 164 barriers or facilitators affecting implementation of 
evidence were identified from 63 studies, although 36.5% were rated as being of 
poor methodological quality. Excluding the poor methodological quality studies, 
we saw that aspects related to patients and health professionals have been 
studied most (although they are analyzed separately rather than at a relational 
level), while there is a lack of studies focusing on guidelines.
Conclusions: The identified barriers and facilitators can be used in 
subsequent qualitative studies to explore in more depth what makes guidelines 
difficult or easy to implement. More studies have to be conducted focusing on 
relational aspects, that is, how patients and professionals interact mutually, and 
how they interact with environment or organization.  
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which may be influencing such implementation [7].
The goal of our study was to identify barriers and facilitators for 
implementing clinical or public health recommendations in order 
to provide useful insights into the design of strategies to better put 
into practice health research outcomes. For these purposes, three 
common health problems were selected, two non-communicable 
diseases (cardiovascular diseases and cancer) and one communicable 
(sexually transmitted infections), which are representing the major 
causes of death worldwide [8], and for which preventive and clinical 
recommendations are widely available.
Explicitly, the objective of this study was to systematically review 
the evidence reported in the literature about cancer, heart and sexually 
transmitted diseases on facilitators and barriers to the implementation 
of research findings in the health care setting, identify which barriers 
and facilitators are more often studied, and what relationships exist 
between them, if any.
Methods
Search strategy and inclusion criteria of papers
A literature review protocol was designed and studies to be 
included were retrieved from the MedLine bibliographic database. 
Flow diagram of papers selection was reported according to the 
PRISMA statement [9]. The bibliographic search was conducted for 
the period 2009 to 2011 and additional papers were identified by 
searching the reference list of retrieved articles. 
Background
In the assessment of health policies and programs, it is 
important to identify the reasons for adoption and adherence of 
evidenced-based interventions and recommendations by health 
professionals and patients. Clinical practice guidelines (CPG) are a 
major vehicle translating complex research findings into evidenced-
based recommendations. Research on their implementation has 
consistently shown that modest improvements in health care can 
be achieved [1]; however few studies provide a clear rationale for 
selection of the implementation strategy [2]. To understand the 
impact of either their implementation or potential to spread, attention 
must be paid primarily to issues related to decision makers and those 
people potentially required to adopt them [3]. Therefore, factors that 
underpin the reasons for adherence to or adoption of evidence-based 
health interventions by both health professionals and patients need 
to be identified.
Several studies have identified major barriers to clinical or public 
health guidelines use and implementation [4]. All are related to the 
guidelines themselves, patients, lack of time, and resources or support 
to implement recommendations [5]. Moreover, barriers differ by type 
of guideline, demographic characteristics of health care providers 
and type of practice setting [6]. Consequently, generalization of 
the implementation of results to health services different from 
those in which the research was conducted is very difficult, mainly 
because there is little knowledge about attitudes and preferences of 
professionals and patients, or about elements of the health system 
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The search strategy, based on the explicit criteria and focused on 
the specific diseases already mentioned, was as follows: [interventions 
OR recommendations] AND [cardiovascular disease OR cancer OR 
(STI) OR sexual transmission] AND [health impact OR (clinical 
practice) OR (CPG) OR (policy makers) OR (health outcome)] AND 
[disseminat* OR implement* OR decision-making OR stakeholder* 
OR barrier* OR bedside to practice OR enabler*]. 
One reviewer screened the search results looking for studies 
considered eligible based on their title and abstract. We selected 
articles using quantitative or qualitative analyses that reported 
on barriers or facilitators to evidence-based research translation 
into health decision making. Thus, inclusion criteria were: papers 
published in English, Spanish or French languages, focused on cancer, 
cardiovascular disease or sexually transmitted infectious diseases, 
and studying potential barriers and/or facilitators for guideline 
recommendations implementation.
Study quality assessment
Study features and outcomes were entered in a database 
specifically designed for the review. Quality criteria for original papers 
were based on Alberta Heritage Foundation for Medical Research 
[10]. Compliance of each item was rated as 2, 1 or 0. Quantitative 
studies were assessed using 14 different items, so the maximum score 
possible was 28. High quality studies were graded as “++” (score over 
21), moderate quality ones as “+” (15 – 21 points) and poor quality 
were graded as ‘-’ (less than 14 points). In the case of qualitative 
studies, 10 items were used (maximum score 20). Again, studies were 
considered as having a high (over 15 points; ‘++’), moderate (11 – 15 
points: ‘+’) or poor quality (below 11 points; ‘-‘).Finally, systematic 
reviews were also rated. Quality assessment was performed using 
SIGN criteria (maximum score 12 points, referred to 6 items), [11] 
and were also considered as high (over 9; ‘++’), moderate (7 – 9 
points; ‘+’) and poor quality (below 7; ‘-‘).
Data extraction and synthesis
Data extraction was performed by six reviewers. We performed 
evidence tables retrieving for each paper data about: study design, 
target population, intervention studied, disease, implementation 
agent, guideline/recommendation, dissemination channel, results of 
the study, methodological quality according to the above mentioned 
criteria, and barrier or facilitator studied. 
Barriers and facilitators identified were listed according to 
what was found in the literature and then grouped into categories 
and subcategories by means of a consensus meeting with almost 
all members of the research team (n=6) using a Nominal Group 
Technique [12]. All of them were after wards related to the 
methodological quality of the papers where they were studied.
Barriers and facilitators are rarely studied alone. Indeed, studies 
largely include more than one subcategory in their analyses for which 
we found of interest to show the existing relationships between 
different subcategories of barriers or facilitators. In this case, we 
selected studies that focused on more than one subcategory and by 
means of a symmetric matrix we could relate barriers/facilitators 
as they appear in these studies. Specific software packages for the 
analysis of social network data and network visualization (UCINET 
6.0 and Net Draw software) were used. All analyses were done for 
all the studies identified, but also stratified by their methodological 
quality. The resulting networks show which barriers and facilitators 
are studied together. Figures show squares (barrier/facilitator 
subcategory) linked by lines. Square size indicates the number of 
documents where each group of barriers/facilitators has been studied, 
and line thickness the number of papers where the two linked barrier/
facilitator groups have been studied together.
Results
Search results yielded 835 papers (Figure 1), 752 of which 
were excluded after reviewing the abstract for being duplicates or 
for not addressing barriers/facilitators for the implementation of 
guideline recommendations. Then, after checking full-text papers for 
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Figure 1: Flow diagram of selection of papers for inclusion in the review.
Figure 2: Co-occurrence of barriers/facilitators subcategories in the 40 high 
or moderate methodological quality papers.
Abbreviated categories: PAT: Patients; PROF: Health Professionals; REL: 
Patient-Professional Relationship; GUIDE: Guideline Characteristics; ORG: 
Organization. ENVIRON: Environment.
Abbreviated subcategories: PAT Attitudes: Patient Attitudes; PAT Socioec: 
Patient Socioeconomic Characteristics; PAT Char: Patient Demographic 
Characteristics; PAT Clin: Patient Clinical Characteristics And Functionalities; 
PAT Know: Patient Knowledge; PAT Family: Patient’s Family; PROF Char: 
Professional Characteristics; PROF Know: Professional Knowledge; 
PROF Attitudes: Professional Attitudes; REL Skills: Patient-Professional 
Relationship Skills; REL Attitudes: Patient-Professional Relationship Attitudes 
; ORG Macro: Organization Macro Level; ORG Meso: Organization Meso 
Level; ORG Micro: Organization Micro Level; GUIDE Additional: Guideline 
Additional Instruments; GUIDE Format: Guideline Format; GUIDE Content: 
Guideline Content. 
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coherency between content and our stated aim, a further 20 papers 
were excluded. Thus, 63 documents were finally selected for critical 
appraisal and classified according to their methodological quality. 
There is a remarkable heterogeneity between studies, being 50% of 
them qualitative yet nearly half of all qualitative studies were ranked 
as poor quality (Table 1). 
Critical appraisal of the selected studies allowed for the 
identification of a large number of possible barriers or facilitators 
(n=164) to evidence implementation. By means of a modified 
Nominal Group Technique, they were classified into 6 different 
categories and 17 subcategories as displayed in Table 2. We found 
that attitudes, beliefs and preferences were barriers or facilitators 
both in patients and health professionals, although amongst patients 
we found aspects such as risk perception, adherence to medication 
or inability to change habits, while amongst health professionals 
other aspects were studied, e.g. skepticism, clinical inertia or lack 
of agreement with clinical recommendations. Similarly, although 
knowledge barriers were found in patients as well as in professionals, 
in one case they were more related to patient awareness of clinical 
situation and treatment options while for professionals were more 
related to expertise or strategies for keeping up to date. Regarding 
patient-professional relationship skills, linguistic problems or 
incorrect interpretation of recommendations were found as barriers 
for guideline implementation. Finally, it is worth mentioning some 
enablers related to additional instruments to the guideline, especially 
those studied in high quality papers such as: use of clinical decision 
support systems, online availability of the guideline or telephone 
counseling.
After constructing the barriers/facilitators group relations matrix 
stratifying by papers methodological quality, and restricting our 
attention to those of high or moderate methodological quality (Figure 
2), we saw that aspects related to patients and health professionals, as 
well as those related to health policies (organization at macro level), 
have been studied most (biggest square sizes), while there is a lack 
of studies focusing on environment, guidelines and management at 
clinical level.
In addition, since line thickness shows number of documents 
where the two linked aspects have been studied together, it can be 
inferred from Figure 2 that patient attitudes have often been studied 
with patient and health professional knowledge. On the other hand, 
there are few good quality papers studying patient-professional 
relationships together with guideline characteristics. Thus, 
researchers are interested in studying barriers/facilitators related to 
professionals and patients, but they are not paying attention to the 
relationship between them. Indeed, professional- and patient-related 
aspects are analyzed separately rather than at a relational level (e.g. 
shared decision-making).
Discussion
Our review identified 164 possible barriers or facilitators 
affecting implementation of health recommendations about cancer, 
heart and sexually transmitted diseases, through an analysis of 
63 studies, although 36.5% (23 out of 63) were rated as being of 
poor methodological quality. Taking into account only the high 
and moderate methodological quality studies we saw that aspects 
related to patients and health professionals, as well as those related 
to health policies, have been studied most, while there is a lack of 
studies focusing on guidelines. It is somehow surprising that so little 
has been studied on guidelines since one would think that format, 
dissemination or clinical decision tools for implementing them are 
essential elements for guideline implementation. Given that we 
are dealing with knowledge translation, it is certainly unexpected 
that so little is reported about barriers or facilitators related to the 
designed tool for knowledge translation, that is, guidelines. Although 
considerable effort has been devoted to developing high quality 
guidelines, there is scarce evidence regarding how development 
criteria may affect their implementation. It seems, therefore, that 
guidelines themselves have not been sufficiently studied as a potential 
barrier or facilitator. So, the results of our study may be biased because 
of researcher choice of study object in the original papers.
The fact that aspects related to patients and professionals are 
the most studied is probably because of data availability. The ease 
with which data may be obtained determines the object on which 
research is conducted, and even the methodology used. Thus, studies 
analyzing patient factors are mainly quantitative because they are, 
statistically speaking, a big and captive sample. Eg, patients admitted 
to hospital can be approached by a questionnaire at different points 
in time. In addition, they are not qualitatively interviewed with open 
questions because it is generally believed that they cannot offer an 
expert opinion. On the other hand, professional barriers/facilitators 
are mostly studied by qualitative methodology because in this case 
it is more difficult to obtain a statistically representative sample and 
besides that, they are considered experts and, therefore, studies using 
exploratory and open interviews are common.
Our study shows what has been studied in three major health 
High quality 
(++)
Moderate quality 
(+)
Poor quality 
(-) Total
Quantitative 
studies 7
[13-19] 13[31-43] 2[53,54] 22
Qualitative 
studies 10
[20-29] 8[44-51] 14[55-68] 32
Reviews 1[30] 1[52] 7[69-75] 9
Total 18 22 23 63
Table 1: Number of selected studies according to type of study and its quality.
Category Subcategory (number of barriers/facilitators)
Patients
• Demographic characteristics (n=2)
• Socioeconomic characteristics (n=2)
• Clinical characteristics and functionalities 
(n=8)
• Knowledge (n=8)
• Family (n=2)
• Attitudes, beliefs and preferences (n=18)
Health professionals
• Professional characteristics (n=2)
• Knowledge or skills (n=12)
• Attitudes, beliefs and preferences (n=12)
Patient-professional 
relationship
• Skills (n=5)
• Attitudes (n=14)
Guideline characteristics
• Format (n=6)
• Content (n=14)
• Additional instruments (n=11)
Organization
•	 Micro level: clinical management (n=14)
•	 Meso level: small structure management 
(n=16)
•	 Macro level: policies (n=13)
Environment • Environment (n=5)
Table 2: Categories and subcategories for barriers and/or facilitators.
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conditions, and therefore what is known from the evidence-based 
point of view in these cases. However, this evidence may or may 
not be consistent with that which may be found in different health 
care settings or different countries. In addition, this evidence reveals 
barriers and facilitators but it does not offer an explanation of why 
they are so or which ones are the most important, in what settings and 
with what stakeholders (physicians, nurses, patients, managers and 
so on). Moreover, in some cases a given item has been identified as a 
barrier in one study and as a facilitator in another, or one may even 
be on the causal path of the other. In depth high quality qualitative 
studies are needed in this regard.
Therefore, a limitation of this study is that we only considered 
heart, cancer and sexually transmitted diseases and a publication 
period of just three years. However, firstly, searching had to be 
limited as otherwise it would have been impossible to review all 
literature; secondly, we included reviews in our search, so we probably 
captured previous original papers through the reviews; and thirdly, 
these diseases were carefully selected to include a diverse range of 
clinical conditions and because they are diseases where clinical and 
public health evidence-based recommendations have been widely 
published. We feel confident that adding conditions or extending the 
publication period of our literature search would have not revealed 
new categories or subcategories of barriers or facilitators. As a matter 
of fact, other literature reviews came up with similar categories when 
studying specific clinical conditions or specialties like spinal cord 
injury, [76] ICU, [77] or physiotherapy, [78] or when focusing on 
particular stakeholders like policy makers [79].
A strength of our study, besides its broader spectrum, is that 
we aimed at not only identifying as much as possible barriers 
and facilitators (studied through any design, quantitatively or 
qualitatively), but also looking at which ones were studied most and 
looking for relationships between them. We are aware that this is not 
a typical objective for a systematic review. However, it is acceptable 
for a scoping review [80]. Thus, to fulfill our aim we had to adapt 
the already known methodology and somehow innovate with it. To 
do so, we had to apply different methodological quality instruments 
depending on the study design in order to dismiss poor quality papers 
for the relationship analysis. Then, to analyze it we made use of a 
technique which is usually employed for social network data. As far 
as we know, this type of analysis has never been applied to a literature 
review.
Finally, more investment is needed for implementation research 
since funding agencies allocate important resources for research 
into new methods for diagnostics, therapy or prevention and for 
studying mechanisms of disease but very little funding to how the 
implementation of these research findings could take place. Not 
surprisingly, there is little funding allocation to implementation 
itself, for instance, to research on how to modify patient and health 
professional attitudes if they have been identified as a barrier for an 
evidence-based recommendation.
Conclusions
Our review identified numerous barriers and facilitators for 
implementing evidence-based health recommendations than could 
be classified into six groups or categories concerning: patients, health 
professionals, patient-professional relationship, organizational 
aspects, guideline characteristics, and environmental factors.
Regarding those studied in good methodological quality papers, 
we showed that barriers or facilitators related to actors (health 
professionals and patients) are studied more than those concerning 
guidelines or organizations. Furthermore, professional and patient 
aspects are analyzed separately rather than at a relational level. 
Therefore, since knowledge translation is primarily relational, more 
studies have to be conducted focusing on relational aspects, that is, 
how patients and health professionals interact mutually and how they 
interact with the environment or with organizations.
The identified barriers or facilitators will be used in subsequent 
qualitative studies to explore in more depth what makes clinical or 
public health guidelines difficult or easy to implement. These studies 
will involve health professionals, clinical and non-clinical, as well 
as patients, either hospital or primary care users including healthy 
occasional users. Improving insight into implementation enablers 
can help in designing dissemination strategies for health guidelines.
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